|
|
| Nomenclature |
|
Symbol:
|
Tg(Ins2-CD86)12B70Flv
|
|
Name:
|
transgene insertion 12B70, Richard Flavell
|
|
MGI ID: |
MGI:3764558 |
|
Synonyms: |
RIP-CD86 |
|
Transgene:
|
Tg(Ins2-CD86)12B70Flv
Location:
unknown
|
|
Transgene origin |
|
Strain of Origin:
|
(C57BL/6 x CBA/Ca)F2
|
|
Transgene description |
|
Transgene
Type: | |
Transgenic (random, expressed) |
|
Mutation: | |
Insertion |
| |
|
Mutation details: The transgenic construct contains the human CD86 gene driven by the rat insulin 2 promoter (RIP). Transgenic protein expression is restricted to the Islets of Langerhans. (J:93555)
|
|
Inheritance: | |
Dominant |
|
Phenotypes
|
View phenotypes for all genotypes (concatenated display).
|
|
Disease models
|
|
| Find Mice (IMSR) |
Mouse strains and cell lines available from the
International Mouse Strain Resource
(IMSR)
|
| References |
|
Original: |
J:93555
Guerder S et al.,
"Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes."
J Immunol 1998 Sep 1;161(5):2128-40
|
|
All: |
3 reference(s)
|
|